

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.91716473 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.91716473 |
| 3 | viral transcription (GO:0019083) | 7.17682771 |
| 4 | translational termination (GO:0006415) | 6.85048923 |
| 5 | fatty acid elongation (GO:0030497) | 6.69340163 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.45295725 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 6.39608932 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 6.36287500 |
| 9 | protein targeting to ER (GO:0045047) | 6.30168477 |
| 10 | translational elongation (GO:0006414) | 6.05800629 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.03441624 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 6.00805945 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 5.70429915 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.56539580 |
| 15 | viral life cycle (GO:0019058) | 5.49346706 |
| 16 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.39997086 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 5.39997086 |
| 18 | myelination (GO:0042552) | 5.39490493 |
| 19 | ensheathment of neurons (GO:0007272) | 5.38057066 |
| 20 | axon ensheathment (GO:0008366) | 5.38057066 |
| 21 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.29492353 |
| 22 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.20491822 |
| 23 | cellular protein complex disassembly (GO:0043624) | 5.18510948 |
| 24 | cholesterol biosynthetic process (GO:0006695) | 5.03449508 |
| 25 | translational initiation (GO:0006413) | 5.03015455 |
| 26 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.91531151 |
| 27 | ribosomal large subunit biogenesis (GO:0042273) | 4.88556329 |
| 28 | regulation of mitochondrial translation (GO:0070129) | 4.57422444 |
| 29 | protein complex disassembly (GO:0043241) | 4.42571538 |
| 30 | sterol biosynthetic process (GO:0016126) | 4.39889576 |
| 31 | respiratory electron transport chain (GO:0022904) | 4.39397339 |
| 32 | translation (GO:0006412) | 4.39050832 |
| 33 | protein targeting to membrane (GO:0006612) | 4.38941795 |
| 34 | substantia nigra development (GO:0021762) | 4.34572406 |
| 35 | protein neddylation (GO:0045116) | 4.31383331 |
| 36 | electron transport chain (GO:0022900) | 4.29249666 |
| 37 | macromolecular complex disassembly (GO:0032984) | 4.27544297 |
| 38 | establishment of mitochondrion localization (GO:0051654) | 4.21127287 |
| 39 | negative regulation of protein localization to cell surface (GO:2000009) | 4.20553218 |
| 40 | chaperone-mediated protein transport (GO:0072321) | 4.20032258 |
| 41 | formation of translation preinitiation complex (GO:0001731) | 4.15428083 |
| 42 | proteasome assembly (GO:0043248) | 3.95358597 |
| 43 | regulation of collateral sprouting (GO:0048670) | 3.92236367 |
| 44 | isoprenoid biosynthetic process (GO:0008299) | 3.85449847 |
| 45 | negative regulation of neurotransmitter transport (GO:0051589) | 3.79965563 |
| 46 | oligodendrocyte differentiation (GO:0048709) | 3.75719028 |
| 47 | presynaptic membrane organization (GO:0097090) | 3.70020799 |
| 48 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.66041910 |
| 49 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.65992397 |
| 50 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.63682243 |
| 51 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.63682243 |
| 52 | NADH dehydrogenase complex assembly (GO:0010257) | 3.63682243 |
| 53 | presynaptic membrane assembly (GO:0097105) | 3.62181916 |
| 54 | L-phenylalanine metabolic process (GO:0006558) | 3.60530652 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.60530652 |
| 56 | myelin maintenance (GO:0043217) | 3.60037155 |
| 57 | cellular component biogenesis (GO:0044085) | 3.57141148 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.49952406 |
| 59 | L-phenylalanine catabolic process (GO:0006559) | 3.49952406 |
| 60 | mRNA catabolic process (GO:0006402) | 3.47820688 |
| 61 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.47005195 |
| 62 | GPI anchor biosynthetic process (GO:0006506) | 3.46753307 |
| 63 | amyloid precursor protein metabolic process (GO:0042982) | 3.46338231 |
| 64 | response to redox state (GO:0051775) | 3.43121185 |
| 65 | photoreceptor cell differentiation (GO:0046530) | 3.43120815 |
| 66 | eye photoreceptor cell differentiation (GO:0001754) | 3.43120815 |
| 67 | GDP-mannose metabolic process (GO:0019673) | 3.39900722 |
| 68 | protein targeting to mitochondrion (GO:0006626) | 3.37356907 |
| 69 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.36525721 |
| 70 | astrocyte development (GO:0014002) | 3.34413796 |
| 71 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.33937767 |
| 72 | apical protein localization (GO:0045176) | 3.33733754 |
| 73 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.32301645 |
| 74 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.31943966 |
| 75 | termination of RNA polymerase III transcription (GO:0006386) | 3.30810957 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.30810957 |
| 77 | protein maturation by protein folding (GO:0022417) | 3.29682211 |
| 78 | neuron cell-cell adhesion (GO:0007158) | 3.28835689 |
| 79 | secondary metabolite biosynthetic process (GO:0044550) | 3.27406267 |
| 80 | establishment of protein localization to membrane (GO:0090150) | 3.27028275 |
| 81 | mannosylation (GO:0097502) | 3.24407995 |
| 82 | establishment of protein localization to mitochondrion (GO:0072655) | 3.22202447 |
| 83 | melanin biosynthetic process (GO:0042438) | 3.21940527 |
| 84 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.20358378 |
| 85 | negative regulation of ligase activity (GO:0051352) | 3.20358378 |
| 86 | protein complex biogenesis (GO:0070271) | 3.19735080 |
| 87 | GPI anchor metabolic process (GO:0006505) | 3.18093339 |
| 88 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.14149588 |
| 89 | rRNA modification (GO:0000154) | 3.13442658 |
| 90 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.13045128 |
| 91 | RNA catabolic process (GO:0006401) | 3.11759989 |
| 92 | protein targeting (GO:0006605) | 3.07592754 |
| 93 | regulation of dopamine metabolic process (GO:0042053) | 3.07013119 |
| 94 | regulation of catecholamine metabolic process (GO:0042069) | 3.07013119 |
| 95 | protein localization to mitochondrion (GO:0070585) | 3.06630115 |
| 96 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.04516246 |
| 97 | limb bud formation (GO:0060174) | 3.03026473 |
| 98 | regulation of somitogenesis (GO:0014807) | 3.01329253 |
| 99 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.01000955 |
| 100 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00683672 |
| 101 | dopamine biosynthetic process (GO:0042416) | 2.97970273 |
| 102 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.97294073 |
| 103 | neural nucleus development (GO:0048857) | 2.97079013 |
| 104 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.95846521 |
| 105 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.94372169 |
| 106 | proline biosynthetic process (GO:0006561) | 2.93781128 |
| 107 | glycerophospholipid catabolic process (GO:0046475) | 2.91940323 |
| 108 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.91651558 |
| 109 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.88060480 |
| 110 | cytochrome complex assembly (GO:0017004) | 2.87798218 |
| 111 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.85860593 |
| 112 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.85860593 |
| 113 | spliceosomal snRNP assembly (GO:0000387) | 2.85664328 |
| 114 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.85237284 |
| 115 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.85237284 |
| 116 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.85237284 |
| 117 | establishment of integrated proviral latency (GO:0075713) | 2.84344798 |
| 118 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.83383916 |
| 119 | response to methylmercury (GO:0051597) | 2.82333095 |
| 120 | galactose catabolic process (GO:0019388) | 2.80469742 |
| 121 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.78726184 |
| 122 | creatine metabolic process (GO:0006600) | 2.78628502 |
| 123 | establishment of protein localization to organelle (GO:0072594) | 2.78602685 |
| 124 | asymmetric protein localization (GO:0008105) | 2.78039454 |
| 125 | 7-methylguanosine mRNA capping (GO:0006370) | 2.77789740 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.76971982 |
| 127 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.76971982 |
| 128 | protein palmitoylation (GO:0018345) | 2.76157211 |
| 129 | DNA strand renaturation (GO:0000733) | 2.75929988 |
| 130 | rRNA processing (GO:0006364) | 2.74514930 |
| 131 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.72230203 |
| 132 | melanin metabolic process (GO:0006582) | 2.71345112 |
| 133 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.70966655 |
| 134 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.70533883 |
| 135 | metallo-sulfur cluster assembly (GO:0031163) | 2.69011761 |
| 136 | iron-sulfur cluster assembly (GO:0016226) | 2.69011761 |
| 137 | respiratory chain complex IV assembly (GO:0008535) | 2.68918498 |
| 138 | cranial nerve development (GO:0021545) | 2.68480408 |
| 139 | cullin deneddylation (GO:0010388) | 2.68394723 |
| 140 | rRNA methylation (GO:0031167) | 2.67822745 |
| 141 | 7-methylguanosine RNA capping (GO:0009452) | 2.67765430 |
| 142 | RNA capping (GO:0036260) | 2.67765430 |
| 143 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.67324590 |
| 144 | amyloid precursor protein catabolic process (GO:0042987) | 2.67032121 |
| 145 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.63812685 |
| 146 | peptidyl-histidine modification (GO:0018202) | 2.63631223 |
| 147 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.63568431 |
| 148 | nucleotide transmembrane transport (GO:1901679) | 2.62153840 |
| 149 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.59775439 |
| 150 | glial cell development (GO:0021782) | 2.59338705 |
| 151 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.59332568 |
| 152 | transmission of nerve impulse (GO:0019226) | 2.59043512 |
| 153 | microtubule polymerization or depolymerization (GO:0031109) | 2.58673228 |
| 154 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.58159163 |
| 155 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.55412990 |
| 156 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.55412990 |
| 157 | hydrogen ion transmembrane transport (GO:1902600) | 2.54565413 |
| 158 | cellular copper ion homeostasis (GO:0006878) | 2.53869005 |
| 159 | negative regulation of axonogenesis (GO:0050771) | 2.53817682 |
| 160 | peptidyl-cysteine modification (GO:0018198) | 2.50269192 |
| 161 | establishment of viral latency (GO:0019043) | 2.50137749 |
| 162 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.50084461 |
| 163 | ATP biosynthetic process (GO:0006754) | 2.49805189 |
| 164 | neurotransmitter uptake (GO:0001504) | 2.49322600 |
| 165 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.49200764 |
| 166 | negative regulation of axon extension (GO:0030517) | 2.48089439 |
| 167 | C-terminal protein lipidation (GO:0006501) | 2.47822432 |
| 168 | GTP biosynthetic process (GO:0006183) | 2.47085274 |
| 169 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.46839193 |
| 170 | ribosomal small subunit biogenesis (GO:0042274) | 2.46777037 |
| 171 | cellular response to epinephrine stimulus (GO:0071872) | 2.45438029 |
| 172 | ubiquinone metabolic process (GO:0006743) | 2.45188878 |
| 173 | axon development (GO:0061564) | 2.44214969 |
| 174 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.44150993 |
| 175 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.44150993 |
| 176 | enteric nervous system development (GO:0048484) | 2.43184396 |
| 177 | neuronal action potential propagation (GO:0019227) | 2.42307422 |
| 178 | regulation of feeding behavior (GO:0060259) | 2.41563867 |
| 179 | inner mitochondrial membrane organization (GO:0007007) | 2.38377317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.29588746 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.39021017 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.35489598 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.29545871 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.23699339 |
| 6 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.90075097 |
| 7 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.79783173 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.72522111 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.60373592 |
| 10 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.55439161 |
| 11 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.46167023 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.44275877 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.43680348 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41499280 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.39703571 |
| 16 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37026609 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.33338045 |
| 18 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.30952807 |
| 19 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.22261711 |
| 20 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.13822485 |
| 21 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.10534202 |
| 22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.09358959 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.08195604 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.06747820 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.02097216 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.95577252 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.87975388 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.87440222 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.86478513 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83253518 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82548297 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81898079 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.81790366 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.80362440 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80264029 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80147953 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.75725184 |
| 38 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.75347707 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.73748600 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.69961216 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69243849 |
| 42 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.68698488 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66542866 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.65195747 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.63814727 |
| 46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63556771 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.58882775 |
| 48 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58721625 |
| 49 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.56563663 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55661485 |
| 51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.50894510 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49946604 |
| 53 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.49078007 |
| 54 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48402154 |
| 55 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.48010378 |
| 56 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.46974530 |
| 57 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.46241050 |
| 58 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.46241050 |
| 59 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.46241050 |
| 60 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.45852312 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45300721 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.44867472 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44347010 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.44292759 |
| 65 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38774627 |
| 66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37740264 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36521542 |
| 68 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36521542 |
| 69 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.35397188 |
| 70 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.34606544 |
| 71 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.33461513 |
| 72 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.32896346 |
| 73 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31834832 |
| 74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31526024 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31502797 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29426540 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28631122 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28452823 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28055262 |
| 80 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27591671 |
| 81 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27529964 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.27296003 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26330492 |
| 84 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26203334 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25308232 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25227191 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25026524 |
| 88 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24662920 |
| 89 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.24090764 |
| 90 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.23186315 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22522398 |
| 92 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21503845 |
| 93 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.20778209 |
| 94 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20387971 |
| 95 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.20199207 |
| 96 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.19954485 |
| 97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19559567 |
| 98 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.19039527 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18960017 |
| 100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18757411 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15479330 |
| 102 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14515143 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14037110 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13266594 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11626409 |
| 106 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09911051 |
| 107 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09746234 |
| 108 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.08187719 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08180164 |
| 110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08021282 |
| 111 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06802438 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06617556 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05639321 |
| 114 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05540958 |
| 115 | EWS_26573619_Chip-Seq_HEK293_Human | 1.05005162 |
| 116 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02790456 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02619743 |
| 118 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01746897 |
| 119 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01700324 |
| 120 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00168006 |
| 121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00063045 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99372559 |
| 123 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99288438 |
| 124 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98870645 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98708845 |
| 126 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97968413 |
| 127 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97258060 |
| 128 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96481937 |
| 129 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96401695 |
| 130 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.96195985 |
| 131 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95953823 |
| 132 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95702664 |
| 133 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.95341724 |
| 134 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95076034 |
| 135 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94860526 |
| 136 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94783668 |
| 137 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.94619870 |
| 138 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.93222006 |
| 139 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.93008260 |
| 140 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92531405 |
| 141 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.92019657 |
| 142 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91937171 |
| 143 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91935652 |
| 144 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91489629 |
| 145 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90901162 |
| 146 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90700568 |
| 147 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90303477 |
| 148 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89996970 |
| 149 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89699139 |
| 150 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88939783 |
| 151 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.88878799 |
| 152 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87938388 |
| 153 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87429443 |
| 154 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86805872 |
| 155 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86688550 |
| 156 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86611343 |
| 157 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86360256 |
| 158 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85392990 |
| 159 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85304535 |
| 160 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85221401 |
| 161 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85171743 |
| 162 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84789014 |
| 163 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84401448 |
| 164 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84023835 |
| 165 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.82817344 |
| 166 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80142022 |
| 167 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.79833423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.84324483 |
| 2 | MP0001529_abnormal_vocalization | 3.56719627 |
| 3 | MP0000920_abnormal_myelination | 3.48895404 |
| 4 | MP0003136_yellow_coat_color | 3.04881479 |
| 5 | MP0001905_abnormal_dopamine_level | 2.84678893 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.68138874 |
| 7 | MP0004270_analgesia | 2.62074748 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.46239152 |
| 9 | MP0005075_abnormal_melanosome_morpholog | 2.44121636 |
| 10 | MP0002095_abnormal_skin_pigmentation | 2.26434783 |
| 11 | MP0003329_amyloid_beta_deposits | 2.20803515 |
| 12 | MP0000566_synostosis | 2.20702867 |
| 13 | MP0005171_absent_coat_pigmentation | 2.18020236 |
| 14 | MP0001485_abnormal_pinna_reflex | 2.15323888 |
| 15 | MP0003693_abnormal_embryo_hatching | 2.14054285 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.13262857 |
| 17 | MP0003186_abnormal_redox_activity | 2.11475236 |
| 18 | MP0002272_abnormal_nervous_system | 2.09065143 |
| 19 | MP0004885_abnormal_endolymph | 2.07767738 |
| 20 | MP0004742_abnormal_vestibular_system | 2.05396271 |
| 21 | MP0004142_abnormal_muscle_tone | 2.04822486 |
| 22 | MP0000778_abnormal_nervous_system | 2.03381221 |
| 23 | MP0010386_abnormal_urinary_bladder | 1.93213285 |
| 24 | MP0008058_abnormal_DNA_repair | 1.92414646 |
| 25 | MP0002132_abnormal_respiratory_system | 1.88858761 |
| 26 | MP0002064_seizures | 1.85289406 |
| 27 | MP0003634_abnormal_glial_cell | 1.82976081 |
| 28 | MP0010094_abnormal_chromosome_stability | 1.82287912 |
| 29 | MP0002160_abnormal_reproductive_system | 1.81301943 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77881037 |
| 31 | MP0001293_anophthalmia | 1.75546480 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.74245078 |
| 33 | MP0001486_abnormal_startle_reflex | 1.71630009 |
| 34 | MP0003786_premature_aging | 1.66509837 |
| 35 | MP0004957_abnormal_blastocyst_morpholog | 1.64453922 |
| 36 | MP0001324_abnormal_eye_pigmentation | 1.64317465 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.63169205 |
| 38 | MP0000462_abnormal_digestive_system | 1.62709472 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.62648086 |
| 40 | MP0002736_abnormal_nociception_after | 1.62378560 |
| 41 | MP0004381_abnormal_hair_follicle | 1.56940409 |
| 42 | MP0002938_white_spotting | 1.55530355 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.55506149 |
| 44 | MP0004133_heterotaxia | 1.54938928 |
| 45 | MP0009745_abnormal_behavioral_response | 1.54275336 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.53981004 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.53932946 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.53152320 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.50528953 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.50104424 |
| 51 | MP0003690_abnormal_glial_cell | 1.49168594 |
| 52 | MP0002229_neurodegeneration | 1.48512753 |
| 53 | MP0000955_abnormal_spinal_cord | 1.46488794 |
| 54 | MP0010030_abnormal_orbit_morphology | 1.45356771 |
| 55 | MP0003315_abnormal_perineum_morphology | 1.44260745 |
| 56 | MP0004043_abnormal_pH_regulation | 1.43334375 |
| 57 | MP0003122_maternal_imprinting | 1.42782983 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.42472641 |
| 59 | MP0001440_abnormal_grooming_behavior | 1.40721700 |
| 60 | MP0003632_abnormal_nervous_system | 1.38604226 |
| 61 | MP0003077_abnormal_cell_cycle | 1.38262951 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.36590938 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.36561990 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.36213851 |
| 65 | MP0003938_abnormal_ear_development | 1.35222876 |
| 66 | MP0001970_abnormal_pain_threshold | 1.34611511 |
| 67 | MP0002733_abnormal_thermal_nociception | 1.34353533 |
| 68 | MP0002735_abnormal_chemical_nociception | 1.34092065 |
| 69 | MP0004272_abnormal_basement_membrane | 1.33689173 |
| 70 | MP0000371_diluted_coat_color | 1.32683741 |
| 71 | MP0001963_abnormal_hearing_physiology | 1.31897959 |
| 72 | MP0004859_abnormal_synaptic_plasticity | 1.31326087 |
| 73 | MP0009379_abnormal_foot_pigmentation | 1.30454168 |
| 74 | MP0002882_abnormal_neuron_morphology | 1.30324047 |
| 75 | MP0002139_abnormal_hepatobiliary_system | 1.29917408 |
| 76 | MP0002063_abnormal_learning/memory/cond | 1.27840149 |
| 77 | MP0000358_abnormal_cell_content/ | 1.26791555 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.25892187 |
| 79 | MP0002752_abnormal_somatic_nervous | 1.24989081 |
| 80 | MP0009046_muscle_twitch | 1.22650880 |
| 81 | MP0005197_abnormal_uvea_morphology | 1.22228463 |
| 82 | MP0004134_abnormal_chest_morphology | 1.20892852 |
| 83 | MP0004924_abnormal_behavior | 1.19506960 |
| 84 | MP0005386_behavior/neurological_phenoty | 1.19506960 |
| 85 | MP0000750_abnormal_muscle_regeneration | 1.18332859 |
| 86 | MP0000026_abnormal_inner_ear | 1.17689036 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 1.15192580 |
| 88 | MP0002067_abnormal_sensory_capabilities | 1.14187102 |
| 89 | MP0005451_abnormal_body_composition | 1.12764135 |
| 90 | MP0001186_pigmentation_phenotype | 1.12450901 |
| 91 | MP0000762_abnormal_tongue_morphology | 1.10571513 |
| 92 | MP0002697_abnormal_eye_size | 1.09800256 |
| 93 | MP0002751_abnormal_autonomic_nervous | 1.09048427 |
| 94 | MP0000749_muscle_degeneration | 1.08808628 |
| 95 | MP0004036_abnormal_muscle_relaxation | 1.08663313 |
| 96 | MP0003111_abnormal_nucleus_morphology | 1.08434396 |
| 97 | MP0002075_abnormal_coat/hair_pigmentati | 1.08253035 |
| 98 | MP0005085_abnormal_gallbladder_physiolo | 1.07695167 |
| 99 | MP0000372_irregular_coat_pigmentation | 1.04923326 |
| 100 | MP0002184_abnormal_innervation | 1.04821896 |
| 101 | MP0005410_abnormal_fertilization | 1.02990371 |
| 102 | MP0005365_abnormal_bile_salt | 1.02729715 |
| 103 | MP0003937_abnormal_limbs/digits/tail_de | 1.01979896 |
| 104 | MP0008995_early_reproductive_senescence | 1.00949737 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.99776562 |
| 106 | MP0008789_abnormal_olfactory_epithelium | 0.99701851 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.99619565 |
| 108 | MP0002152_abnormal_brain_morphology | 0.98247473 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.98112133 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.98080518 |
| 111 | MP0001299_abnormal_eye_distance/ | 0.96263349 |
| 112 | MP0000049_abnormal_middle_ear | 0.94792424 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.93877191 |
| 114 | MP0005253_abnormal_eye_physiology | 0.93859190 |
| 115 | MP0000751_myopathy | 0.93743856 |
| 116 | MP0005195_abnormal_posterior_eye | 0.93253210 |
| 117 | MP0003718_maternal_effect | 0.91909752 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.90276253 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.88932157 |
| 120 | MP0003631_nervous_system_phenotype | 0.88832232 |
| 121 | MP0002102_abnormal_ear_morphology | 0.88617102 |
| 122 | MP0001881_abnormal_mammary_gland | 0.88184436 |
| 123 | MP0002092_abnormal_eye_morphology | 0.86811600 |
| 124 | MP0008569_lethality_at_weaning | 0.86502737 |
| 125 | MP0005389_reproductive_system_phenotype | 0.86049988 |
| 126 | MP0005330_cardiomyopathy | 0.85572154 |
| 127 | MP0001188_hyperpigmentation | 0.84207854 |
| 128 | MP0008932_abnormal_embryonic_tissue | 0.83930780 |
| 129 | MP0008007_abnormal_cellular_replicative | 0.83323665 |
| 130 | MP0000747_muscle_weakness | 0.82310773 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.82185434 |
| 132 | MP0002210_abnormal_sex_determination | 0.82140222 |
| 133 | MP0004147_increased_porphyrin_level | 0.81841292 |
| 134 | MP0005083_abnormal_biliary_tract | 0.81768778 |
| 135 | MP0003878_abnormal_ear_physiology | 0.81491721 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.81491721 |
| 137 | MP0002282_abnormal_trachea_morphology | 0.80979480 |
| 138 | MP0003861_abnormal_nervous_system | 0.80096962 |
| 139 | MP0002877_abnormal_melanocyte_morpholog | 0.79849711 |
| 140 | MP0001727_abnormal_embryo_implantation | 0.79257583 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.78505877 |
| 142 | MP0002653_abnormal_ependyma_morphology | 0.78470567 |
| 143 | MP0005193_abnormal_anterior_eye | 0.78306731 |
| 144 | MP0002163_abnormal_gland_morphology | 0.77553040 |
| 145 | MP0003137_abnormal_impulse_conducting | 0.76949928 |
| 146 | MP0005360_urolithiasis | 0.76499879 |
| 147 | MP0009250_abnormal_appendicular_skeleto | 0.75900079 |
| 148 | MP0002837_dystrophic_cardiac_calcinosis | 0.75745877 |
| 149 | MP0001764_abnormal_homeostasis | 0.75012252 |
| 150 | MP0001984_abnormal_olfaction | 0.74299138 |
| 151 | MP0000537_abnormal_urethra_morphology | 0.74124486 |
| 152 | MP0005332_abnormal_amino_acid | 0.73400675 |
| 153 | MP0005408_hypopigmentation | 0.72410778 |
| 154 | MP0009697_abnormal_copulation | 0.72341694 |
| 155 | MP0002177_abnormal_outer_ear | 0.71201098 |
| 156 | MP0002557_abnormal_social/conspecific_i | 0.70939945 |
| 157 | MP0002295_abnormal_pulmonary_circulatio | 0.70528872 |
| 158 | MP0002233_abnormal_nose_morphology | 0.68338554 |
| 159 | MP0002249_abnormal_larynx_morphology | 0.66436774 |
| 160 | MP0001286_abnormal_eye_development | 0.66124050 |
| 161 | MP0005391_vision/eye_phenotype | 0.65815995 |
| 162 | MP0001119_abnormal_female_reproductive | 0.65113735 |
| 163 | MP0001697_abnormal_embryo_size | 0.64718170 |
| 164 | MP0003385_abnormal_body_wall | 0.64676356 |
| 165 | MP0002638_abnormal_pupillary_reflex | 0.64374308 |
| 166 | MP0000653_abnormal_sex_gland | 0.63624148 |
| 167 | MP0003567_abnormal_fetal_cardiomyocyte | 0.62234266 |
| 168 | MP0004019_abnormal_vitamin_homeostasis | 0.61818243 |
| 169 | MP0002090_abnormal_vision | 0.61487106 |
| 170 | MP0000647_abnormal_sebaceous_gland | 0.61465404 |
| 171 | MP0005501_abnormal_skin_physiology | 0.60942946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 4.86213611 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.74396513 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.67340231 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.67340231 |
| 5 | Abnormality of glycolysis (HP:0004366) | 4.62463144 |
| 6 | Increased serum pyruvate (HP:0003542) | 4.62463144 |
| 7 | Neurofibrillary tangles (HP:0002185) | 4.32759495 |
| 8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.29598957 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 4.15445972 |
| 10 | Mitochondrial inheritance (HP:0001427) | 4.12205120 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.02799882 |
| 12 | Cerebral hypomyelination (HP:0006808) | 3.83162303 |
| 13 | Acute encephalopathy (HP:0006846) | 3.80142878 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.80033124 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.70078360 |
| 16 | Macrocytic anemia (HP:0001972) | 3.57425985 |
| 17 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.56446690 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.54187168 |
| 19 | Increased muscle lipid content (HP:0009058) | 3.53619966 |
| 20 | Parakeratosis (HP:0001036) | 3.52585464 |
| 21 | Increased CSF lactate (HP:0002490) | 3.49375683 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.47561143 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.47561143 |
| 24 | Hepatocellular necrosis (HP:0001404) | 3.46245483 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 3.44626773 |
| 26 | Leukodystrophy (HP:0002415) | 3.44583842 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 3.30939116 |
| 28 | Abnormality of the corticospinal tract (HP:0002492) | 3.24823881 |
| 29 | Sensory axonal neuropathy (HP:0003390) | 3.19014941 |
| 30 | Lipid accumulation in hepatocytes (HP:0006561) | 3.18324742 |
| 31 | Alacrima (HP:0000522) | 3.06413950 |
| 32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.95754905 |
| 33 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.87603348 |
| 34 | Partial duplication of thumb phalanx (HP:0009944) | 2.78717565 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 2.76466935 |
| 36 | Cholecystitis (HP:0001082) | 2.76466935 |
| 37 | Peripheral hypomyelination (HP:0007182) | 2.74229248 |
| 38 | Hepatic necrosis (HP:0002605) | 2.73457980 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.71882626 |
| 40 | Hypoplastic pelvis (HP:0008839) | 2.63924090 |
| 41 | CNS hypomyelination (HP:0003429) | 2.62396660 |
| 42 | Pheochromocytoma (HP:0002666) | 2.61514189 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.61244450 |
| 44 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.59647517 |
| 45 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.59647517 |
| 46 | Abnormal protein glycosylation (HP:0012346) | 2.59647517 |
| 47 | Abnormal glycosylation (HP:0012345) | 2.59647517 |
| 48 | Vaginal fistula (HP:0004320) | 2.56571918 |
| 49 | Respiratory failure (HP:0002878) | 2.55331875 |
| 50 | Cupped ear (HP:0000378) | 2.52893411 |
| 51 | Pallor (HP:0000980) | 2.50354070 |
| 52 | Spastic gait (HP:0002064) | 2.49401686 |
| 53 | Morphological abnormality of the inner ear (HP:0011390) | 2.47169900 |
| 54 | Rectal fistula (HP:0100590) | 2.44863415 |
| 55 | Rectovaginal fistula (HP:0000143) | 2.44863415 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.44205693 |
| 57 | Optic disc pallor (HP:0000543) | 2.44125581 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.43569268 |
| 59 | Decreased lacrimation (HP:0000633) | 2.40473807 |
| 60 | Partial duplication of the phalanx of hand (HP:0009999) | 2.37155212 |
| 61 | Methylmalonic acidemia (HP:0002912) | 2.35229023 |
| 62 | Exercise intolerance (HP:0003546) | 2.34936144 |
| 63 | Pancreatic fibrosis (HP:0100732) | 2.33745444 |
| 64 | Thickened helices (HP:0000391) | 2.32511382 |
| 65 | Autoamputation (HP:0001218) | 2.30688071 |
| 66 | Glycosuria (HP:0003076) | 2.29581139 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.29581139 |
| 68 | Aplastic anemia (HP:0001915) | 2.28933091 |
| 69 | Hyperglycinemia (HP:0002154) | 2.28611548 |
| 70 | Patchy hypopigmentation of hair (HP:0011365) | 2.28002219 |
| 71 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.25334166 |
| 72 | White forelock (HP:0002211) | 2.24793457 |
| 73 | Abnormality of the anterior horn cell (HP:0006802) | 2.24185464 |
| 74 | Degeneration of anterior horn cells (HP:0002398) | 2.24185464 |
| 75 | Retinal dysplasia (HP:0007973) | 2.23134073 |
| 76 | Cerebral edema (HP:0002181) | 2.22813920 |
| 77 | Increased intramyocellular lipid droplets (HP:0012240) | 2.22782220 |
| 78 | Anomalous pulmonary venous return (HP:0010772) | 2.20536770 |
| 79 | Testicular atrophy (HP:0000029) | 2.20083439 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.19494332 |
| 81 | Abnormality of methionine metabolism (HP:0010901) | 2.19081528 |
| 82 | Supranuclear gaze palsy (HP:0000605) | 2.18277274 |
| 83 | Hyperphosphaturia (HP:0003109) | 2.16639767 |
| 84 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.16535382 |
| 85 | True hermaphroditism (HP:0010459) | 2.16474390 |
| 86 | Exertional dyspnea (HP:0002875) | 2.15174922 |
| 87 | Increased serum lactate (HP:0002151) | 2.14831361 |
| 88 | Cerebral hemorrhage (HP:0001342) | 2.14183036 |
| 89 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13564550 |
| 90 | Renal tubular dysfunction (HP:0000124) | 2.11660768 |
| 91 | Microvesicular hepatic steatosis (HP:0001414) | 2.10834159 |
| 92 | Absent septum pellucidum (HP:0001331) | 2.10172488 |
| 93 | Aplasia involving bones of the extremities (HP:0009825) | 2.09798260 |
| 94 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.09798260 |
| 95 | Aplasia of the phalanges of the hand (HP:0009802) | 2.09798260 |
| 96 | Termporal pattern (HP:0011008) | 2.07847945 |
| 97 | Insidious onset (HP:0003587) | 2.07847945 |
| 98 | Postnatal microcephaly (HP:0005484) | 2.07790737 |
| 99 | Megalencephaly (HP:0001355) | 2.06774529 |
| 100 | Lethargy (HP:0001254) | 2.06044408 |
| 101 | Lactic acidosis (HP:0003128) | 2.04754863 |
| 102 | Myokymia (HP:0002411) | 2.02064853 |
| 103 | Occipital encephalocele (HP:0002085) | 1.98415254 |
| 104 | Infantile muscular hypotonia (HP:0008947) | 1.98048525 |
| 105 | Delusions (HP:0000746) | 1.97229008 |
| 106 | Medial flaring of the eyebrow (HP:0010747) | 1.97225530 |
| 107 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.96894030 |
| 108 | Nasolacrimal duct obstruction (HP:0000579) | 1.96888765 |
| 109 | Esophageal atresia (HP:0002032) | 1.96418356 |
| 110 | Abnormality of renal resorption (HP:0011038) | 1.95045700 |
| 111 | Septo-optic dysplasia (HP:0100842) | 1.95029808 |
| 112 | Exercise-induced muscle cramps (HP:0003710) | 1.94288553 |
| 113 | Abnormality of reticulocytes (HP:0004312) | 1.92851393 |
| 114 | X-linked dominant inheritance (HP:0001423) | 1.92164653 |
| 115 | Asplenia (HP:0001746) | 1.90777811 |
| 116 | Respiratory difficulties (HP:0002880) | 1.90698909 |
| 117 | Emotional lability (HP:0000712) | 1.90250950 |
| 118 | Pancreatic cysts (HP:0001737) | 1.90054371 |
| 119 | Pancytopenia (HP:0001876) | 1.87757007 |
| 120 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.87047737 |
| 121 | Stenosis of the external auditory canal (HP:0000402) | 1.87043548 |
| 122 | Partial agenesis of the corpus callosum (HP:0001338) | 1.86791463 |
| 123 | Abnormality of the septum pellucidum (HP:0007375) | 1.85801831 |
| 124 | Ankle clonus (HP:0011448) | 1.84787278 |
| 125 | Esophageal neoplasm (HP:0100751) | 1.82894640 |
| 126 | Neoplasm of head and neck (HP:0012288) | 1.82894640 |
| 127 | Calf muscle hypertrophy (HP:0008981) | 1.82551272 |
| 128 | Flat capital femoral epiphysis (HP:0003370) | 1.82254704 |
| 129 | Vaginal atresia (HP:0000148) | 1.81926121 |
| 130 | Abnormality of the pulmonary veins (HP:0011718) | 1.81291492 |
| 131 | Dysmetria (HP:0001310) | 1.79007518 |
| 132 | Congenital hepatic fibrosis (HP:0002612) | 1.77943060 |
| 133 | Irregular epiphyses (HP:0010582) | 1.77109260 |
| 134 | Absent epiphyses (HP:0010577) | 1.76786023 |
| 135 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.76786023 |
| 136 | Sclerocornea (HP:0000647) | 1.76008947 |
| 137 | Abnormality of the fovea (HP:0000493) | 1.75841096 |
| 138 | Mixed hearing impairment (HP:0000410) | 1.74549227 |
| 139 | Flattened epiphyses (HP:0003071) | 1.74534021 |
| 140 | Hypoplastic left heart (HP:0004383) | 1.74507567 |
| 141 | Akinesia (HP:0002304) | 1.74192276 |
| 142 | Hyperglycinuria (HP:0003108) | 1.74091122 |
| 143 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.73824930 |
| 144 | Hypoplasia of the fovea (HP:0007750) | 1.73764684 |
| 145 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.73764684 |
| 146 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.73246099 |
| 147 | Spastic paraparesis (HP:0002313) | 1.73058542 |
| 148 | Premature skin wrinkling (HP:0100678) | 1.72828978 |
| 149 | Genital tract atresia (HP:0001827) | 1.72457963 |
| 150 | Epileptic encephalopathy (HP:0200134) | 1.72417394 |
| 151 | Methylmalonic aciduria (HP:0012120) | 1.71863144 |
| 152 | Duplication of thumb phalanx (HP:0009942) | 1.71251376 |
| 153 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.71208176 |
| 154 | Prolonged partial thromboplastin time (HP:0003645) | 1.70119810 |
| 155 | Double outlet right ventricle (HP:0001719) | 1.69961301 |
| 156 | Congenital malformation of the right heart (HP:0011723) | 1.69961301 |
| 157 | Anteriorly placed anus (HP:0001545) | 1.68553148 |
| 158 | Facial cleft (HP:0002006) | 1.67905704 |
| 159 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.66959959 |
| 160 | Clumsiness (HP:0002312) | 1.66623570 |
| 161 | CNS demyelination (HP:0007305) | 1.66477476 |
| 162 | Secondary amenorrhea (HP:0000869) | 1.65947741 |
| 163 | Intestinal fistula (HP:0100819) | 1.65615849 |
| 164 | Abnormal urine phosphate concentration (HP:0012599) | 1.65096131 |
| 165 | Opisthotonus (HP:0002179) | 1.63009815 |
| 166 | Progressive muscle weakness (HP:0003323) | 1.61130858 |
| 167 | Postaxial foot polydactyly (HP:0001830) | 1.60767993 |
| 168 | Absent thumb (HP:0009777) | 1.60345050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.47740051 |
| 2 | NME2 | 4.58957747 |
| 3 | STK39 | 4.40764216 |
| 4 | BUB1 | 3.52241728 |
| 5 | PDK2 | 3.37095265 |
| 6 | OXSR1 | 3.30922879 |
| 7 | EPHA2 | 3.03095812 |
| 8 | CASK | 2.95952287 |
| 9 | BCKDK | 2.81496603 |
| 10 | BCR | 2.72769100 |
| 11 | PBK | 2.72496059 |
| 12 | CDK19 | 2.54963423 |
| 13 | MST4 | 2.45709417 |
| 14 | MAPKAPK5 | 2.45258963 |
| 15 | NEK1 | 2.34960579 |
| 16 | UHMK1 | 2.29570361 |
| 17 | EPHB2 | 2.26679596 |
| 18 | STK16 | 2.24863742 |
| 19 | WEE1 | 2.21363443 |
| 20 | ZAK | 2.20295797 |
| 21 | EIF2AK1 | 2.15112475 |
| 22 | LIMK1 | 2.08851106 |
| 23 | EPHB1 | 2.06459727 |
| 24 | PKN1 | 1.99428984 |
| 25 | WNK4 | 1.91909137 |
| 26 | PNCK | 1.89948366 |
| 27 | NEK6 | 1.89566257 |
| 28 | FGR | 1.85478292 |
| 29 | TNIK | 1.85076849 |
| 30 | CCNB1 | 1.82216401 |
| 31 | CSNK1G3 | 1.67988600 |
| 32 | DYRK2 | 1.67424942 |
| 33 | MET | 1.66379253 |
| 34 | MST1R | 1.60132955 |
| 35 | ROCK2 | 1.56886103 |
| 36 | CAMK2B | 1.53116474 |
| 37 | ARAF | 1.51143342 |
| 38 | NME1 | 1.49346931 |
| 39 | EPHA4 | 1.43252709 |
| 40 | OBSCN | 1.43017771 |
| 41 | MKNK1 | 1.37406506 |
| 42 | CDC7 | 1.30663532 |
| 43 | MUSK | 1.27886036 |
| 44 | MARK1 | 1.25107532 |
| 45 | LRRK2 | 1.22652476 |
| 46 | TLK1 | 1.22640970 |
| 47 | CHEK2 | 1.22555599 |
| 48 | NTRK1 | 1.20541999 |
| 49 | PRPF4B | 1.19571838 |
| 50 | CSNK1A1L | 1.18984696 |
| 51 | TTK | 1.18176307 |
| 52 | TESK2 | 1.18111512 |
| 53 | VRK1 | 1.16429879 |
| 54 | CLK1 | 1.14277264 |
| 55 | AURKB | 1.13619207 |
| 56 | CSNK1G2 | 1.13208568 |
| 57 | CAMK2D | 1.12836823 |
| 58 | CDK7 | 1.10751289 |
| 59 | CSNK1G1 | 1.09085628 |
| 60 | SMG1 | 1.08594154 |
| 61 | ABL2 | 1.07923375 |
| 62 | GRK7 | 1.07241132 |
| 63 | GRK5 | 1.06804031 |
| 64 | WNK1 | 1.05949680 |
| 65 | CDK14 | 1.05389852 |
| 66 | NEK2 | 1.04168649 |
| 67 | BRSK1 | 1.01744400 |
| 68 | PLK2 | 1.00806236 |
| 69 | NUAK1 | 0.98104183 |
| 70 | PLK4 | 0.96607815 |
| 71 | MAPK13 | 0.91397501 |
| 72 | CDK15 | 0.90809114 |
| 73 | MAPKAPK3 | 0.89359812 |
| 74 | STK4 | 0.89313773 |
| 75 | CDK18 | 0.89179553 |
| 76 | PHKG2 | 0.88075795 |
| 77 | PHKG1 | 0.88075795 |
| 78 | CAMK2A | 0.87901110 |
| 79 | CDK11A | 0.87816273 |
| 80 | IRAK3 | 0.85696252 |
| 81 | PLK1 | 0.82440331 |
| 82 | LMTK2 | 0.82273657 |
| 83 | CSNK2A2 | 0.82225840 |
| 84 | TIE1 | 0.81921775 |
| 85 | ILK | 0.79299409 |
| 86 | CAMK2G | 0.77497602 |
| 87 | CDK5 | 0.76940424 |
| 88 | MAP3K3 | 0.75201501 |
| 89 | RPS6KB2 | 0.74178368 |
| 90 | CSNK2A1 | 0.73841035 |
| 91 | ATR | 0.73195425 |
| 92 | BRAF | 0.72390708 |
| 93 | BMPR1B | 0.71296121 |
| 94 | MAP2K2 | 0.70453185 |
| 95 | FGFR2 | 0.67589584 |
| 96 | KDR | 0.67524087 |
| 97 | MAP3K2 | 0.66408464 |
| 98 | ADRBK2 | 0.65469731 |
| 99 | PRKCE | 0.63820465 |
| 100 | CDK4 | 0.62771045 |
| 101 | RPS6KA5 | 0.62364239 |
| 102 | PAK4 | 0.61803816 |
| 103 | MAPK15 | 0.60031573 |
| 104 | AKT2 | 0.58409404 |
| 105 | ADRBK1 | 0.58157035 |
| 106 | TGFBR1 | 0.57893924 |
| 107 | TAF1 | 0.57306497 |
| 108 | DYRK1A | 0.56592852 |
| 109 | PAK1 | 0.56491469 |
| 110 | MAP4K2 | 0.55527886 |
| 111 | MAP3K4 | 0.55005182 |
| 112 | EIF2AK3 | 0.53666391 |
| 113 | DYRK3 | 0.51029284 |
| 114 | ICK | 0.50918891 |
| 115 | DAPK1 | 0.50253648 |
| 116 | FGFR1 | 0.50055405 |
| 117 | AURKA | 0.48913346 |
| 118 | PAK3 | 0.48241037 |
| 119 | PLK3 | 0.47632188 |
| 120 | SGK494 | 0.46071145 |
| 121 | SGK223 | 0.46071145 |
| 122 | PRKCQ | 0.45617141 |
| 123 | PRKG1 | 0.45499969 |
| 124 | TSSK6 | 0.45441339 |
| 125 | DAPK3 | 0.45425422 |
| 126 | PAK6 | 0.44531098 |
| 127 | BMPR2 | 0.43381175 |
| 128 | IKBKB | 0.43374394 |
| 129 | TYRO3 | 0.39774438 |
| 130 | BRSK2 | 0.39428897 |
| 131 | MELK | 0.38622236 |
| 132 | MKNK2 | 0.38421302 |
| 133 | PRKCI | 0.37952221 |
| 134 | NTRK2 | 0.37011110 |
| 135 | SRPK1 | 0.36922390 |
| 136 | ERBB4 | 0.36809598 |
| 137 | PRKACA | 0.35460464 |
| 138 | MAP2K7 | 0.34917805 |
| 139 | CHEK1 | 0.34447809 |
| 140 | MOS | 0.34067626 |
| 141 | PASK | 0.33452540 |
| 142 | STK3 | 0.33141610 |
| 143 | CDK8 | 0.32819847 |
| 144 | PIM2 | 0.32517468 |
| 145 | PTK2B | 0.31858231 |
| 146 | EIF2AK2 | 0.31619543 |
| 147 | MYLK | 0.31170477 |
| 148 | TESK1 | 0.30247977 |
| 149 | CSNK1A1 | 0.30183615 |
| 150 | PRKD3 | 0.30175286 |
| 151 | PRKACB | 0.29766632 |
| 152 | PIK3CA | 0.29188691 |
| 153 | MARK3 | 0.28881163 |
| 154 | PTK2 | 0.25780725 |
| 155 | GRK1 | 0.25459127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.80130736 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.64683724 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.86793022 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.61408341 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.38504301 |
| 6 | Protein export_Homo sapiens_hsa03060 | 3.29608152 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 3.06755670 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.01063290 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.71230433 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.69183459 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.63417957 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.35112747 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19290979 |
| 14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.18174522 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 2.12540921 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.08954219 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 2.08052464 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.04313211 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.91640456 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.64648823 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.61975956 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.47817529 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42061501 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41375071 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36351669 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.32497741 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29493127 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23148195 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22352421 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21683024 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21308952 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20224032 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17868521 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16349573 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13984952 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13300061 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13133010 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12561955 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12241120 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.10077827 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09557961 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08845429 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07873903 |
| 44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05480742 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01730903 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01384957 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98339187 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94016473 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.93967322 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 0.92702687 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86326313 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86065650 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85531772 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.84683422 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83771298 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79688285 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79518197 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78324063 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76745720 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75559319 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75127852 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.73504790 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.73195133 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72731507 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72342624 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71177610 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70329437 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.69990332 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69271984 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69123607 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68905879 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.68831043 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68289899 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67744061 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66506182 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.65965045 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.65759800 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64858674 |
| 79 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.64778910 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64622730 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63612895 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.62930704 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58832760 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57707824 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57643427 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57637452 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57414753 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.57244885 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.56679812 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55261770 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54620804 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54277845 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53693262 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52806349 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50547814 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50452922 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49702672 |
| 98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48200714 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48161623 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47803443 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.47291209 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46932779 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46630033 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45802610 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.45543622 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45094910 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.44951563 |
| 108 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44471984 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43060131 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42758325 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42252934 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42015174 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.41383830 |
| 114 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40721036 |
| 115 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.38034668 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36393326 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36282804 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.35909807 |
| 119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35702547 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34901806 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33869083 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33104146 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31616904 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.30837107 |
| 125 | RNA transport_Homo sapiens_hsa03013 | 0.30220486 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29949740 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.28995900 |
| 128 | Mismatch repair_Homo sapiens_hsa03430 | 0.27915549 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27692528 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27685329 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27542466 |
| 132 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27524680 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.27448911 |
| 134 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27346593 |
| 135 | Gap junction_Homo sapiens_hsa04540 | 0.26252386 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.25561082 |
| 137 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25181827 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24836892 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24821750 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23498196 |
| 141 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.23471099 |
| 142 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.23442822 |
| 143 | Melanogenesis_Homo sapiens_hsa04916 | 0.23203766 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.22230806 |
| 145 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21457735 |
| 146 | Retinol metabolism_Homo sapiens_hsa00830 | 0.20957083 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.20194736 |
| 148 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.18197063 |
| 149 | Endocytosis_Homo sapiens_hsa04144 | 0.17971671 |
| 150 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.17894088 |
| 151 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.16544740 |
| 152 | Salivary secretion_Homo sapiens_hsa04970 | 0.16360756 |

